"precision cancer medicine" trang 2 - tải miễn phí từ tailieunhanh
Trabectedin arrests a doxorubicin-resistant PDGFRA-activated liposarcoma patientderived orthotopic xenograft (PDOX) nude mouse model

Trabectedin arrests a doxorubicin-resistant PDGFRA-activated liposarcoma patientderived orthotopic xenograft (PDOX) nude mouse model
8    67    0
Distinctive roles of syntaxin binding protein 4 and its action target, TP63, in lung squamous cell carcinoma: A theranostic study for the precision medicine

Distinctive roles of syntaxin binding protein 4 and its action target, TP63, in lung squamous cell carcinoma: A theranostic study for the precision medicine
14    48    1
Comparing the performance of selected variant callers using synthetic data and genome segmentation

Comparing the performance of selected variant callers using synthetic data and genome segmentation
11    62    1
Identification of new candidate biomarkers to support doxorubicin treatments in canine cancer patients

Identification of new candidate biomarkers to support doxorubicin treatments in canine cancer patients
16    49    1
A computable pathology report for precision medicine: Extending an observables ontology unifying SNOMED CT and LOINC

A computable pathology report for precision medicine: Extending an observables ontology unifying SNOMED CT and LOINC
8    6    1
CRISPR-Cas9 identifies growth-related subtypes of glioblastoma with therapeutical significance through cell line knockdown

CRISPR-Cas9 identifies growth-related subtypes of glioblastoma with therapeutical significance through cell line knockdown
14    1    1
Efficacy, safety and biomarker analysis of durvalumab in patients with mismatch-repair deficient or microsatellite instability-high solid tumours

Efficacy, safety and biomarker analysis of durvalumab in patients with mismatch-repair deficient or microsatellite instability-high solid tumours
14    2    1
A multicenter investigator-initiated Phase 2 trial of E7090 in patients with advanced or recurrent solid tumor with fibroblast growth factor receptor (FGFR) gene alteration: FORTUNE trial

A multicenter investigator-initiated Phase 2 trial of E7090 in patients with advanced or recurrent solid tumor with fibroblast growth factor receptor (FGFR) gene alteration: FORTUNE trial
7    2    1
Precision medicine approaches to lung adenocarcinoma with concomitant MET and HER2 amplification

Precision medicine approaches to lung adenocarcinoma with concomitant MET and HER2 amplification
10    54    1
lionessR: Single sample network inference in R

lionessR: Single sample network inference in R
6    76    0
Prediction of the risk of developing hepatocellular carcinoma in health screening examinees: A Korean cohort study

Prediction of the risk of developing hepatocellular carcinoma in health screening examinees: A Korean cohort study
12    46    1
Precision medicine phase II study evaluating the efficacy of a double immunotherapy by durvalumab and tremelimumab combined with olaparib in patients with solid cancers and carriers of homologous recombination repair genes mutation in response or stable after olaparib treatment

Precision medicine phase II study evaluating the efficacy of a double immunotherapy by durvalumab and tremelimumab combined with olaparib in patients with solid cancers and carriers of homologous recombination repair genes mutation in response or stable after olaparib treatment
10    78    1
De novo identification of expressed cancer somatic mutations from single-cell RNA sequencing data

De novo identification of expressed cancer somatic mutations from single-cell RNA sequencing data
18    16    1